Since, changes in 5hmC mtDNA methylation are associated with a wide range of pathological conditions such as cancer, neurodegeneration and aging [65, 93], our observations broaden the current understanding of the development of these diseases and highlight EndoG as a potential target for future therapies. This evidence concerns the gene ENDOG and cancer.